Statistics
Publications
5
Citations
234
H-Index
5
Active since
2003
Affiliations
Ken Chang is an author at Massachusetts General Hospital specializing in radionuclide therapy, medicine, and oncology.
Publications per year
2003–2021
5
5
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
Robert M. Sharkey, William J. McBride, Habibe Karacay et al. · PubMed · 2003 · 94 citations
Medicine, Oncology, Pharmacology +17
Françoise Kraeber‐Bodéré, Alain Faivre-Chauvet, Ludovic Ferrer et al. · PubMed · 2003 · 62 citations
Pharmacy, Oncology, Pharmacokinetics +17
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Robert M. Sharkey, Habibe Karacay, Heidi Richel et al. · PubMed · 2003 · 51 citations
Pharmacy, Oncology, Pharmacology +17
Increased per-patient imaging utilization in an emergency department setting during COVID-19
Marc D. Succi, Ken Chang, Thomas J. An et al. · Clinical Imaging · 2021 · 13 citations · Full text
1–5 of 5